Attached files
| file | filename |
|---|---|
| 8-K - FORM 8-K - Arch Therapeutics, Inc. | v348159_8k.htm |
| EX-21.1 - EXHIBIT 21.1 - Arch Therapeutics, Inc. | v348159_ex21-1.htm |
| EX-10.9 - EXHIBIT 10.9 - Arch Therapeutics, Inc. | v348159_ex10-9.htm |
| EX-10.6 - EXHIBIT 10.6 - Arch Therapeutics, Inc. | v348159_ex10-6.htm |
| EX-10.7 - EXHIBIT 10.7 - Arch Therapeutics, Inc. | v348159_ex10-7.htm |
| EX-99.2 - EXHIBIT 99.2 - Arch Therapeutics, Inc. | v348159_ex99-2.htm |
| EX-99.1 - EXHIBIT 99.1 - Arch Therapeutics, Inc. | v348159_ex99-1.htm |
| EX-10.8 - EXHIBIT 10.8 - Arch Therapeutics, Inc. | v348159_ex10-8.htm |
June 26, 2013
Securities and Exchange Commission
Washington, DC 20549
Ladies and Gentlemen:
We have read Item 4.01 of Form 8-K of Arch Therapeutics, Inc. dated June 26, 2013. We agree with the statements made concerning our firm contained therein.
Yours very truly,
/s/ Paritz & Company, P.A.
Paritz & Company, P.A.